| CHCHD9 — Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 9 | |
|---|---|
| Symbol | CHCHD9 |
| Full Name | Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 9 |
| Chromosome | 9q34.11 |
| NCBI Gene | 55033 |
| Ensembl | ENSG00000177303 |
| OMIM | 614295 |
| UniProt | Q8N5L4 |
| Protein Class | Mitochondrial CHCHD family |
| Diseases | [Parkinson's Disease](/diseases/parkinsons-disease), [Alzheimer's Disease](/diseases/alzheimers), Amyotrophic Lateral Sclerosis |
| Expression | Brain (cerebral [cortex](/brain-regions/cortex), cerebellum), heart, skeletal muscle |
CHCHD9 (Coiled-Coil-Helix-Coiled-Coil-Helix Domain Containing 9) is a nuclear-encoded mitochondrial protein that plays critical roles in mitochondrial function, oxidative phosphorylation, and cellular stress response. The gene is located on chromosome 9q34.11 and encodes a protein containing the conserved CHCHD domain, which is typically found in mitochondrial proteins involved in electron transport chain assembly and maintenance.
CHCHD9 is a member of the CHCHD protein family, which includes CHCHD1, CHCHD2, CHCHD3, CHCHD4, CHCHD6, CHCHD8, and CHCHD10. These proteins share a unique structural motif consisting of two coiled-coil helices connected by a loop that coordinates metal ions essential for mitochondrial electron transport chain function.
CHCHD9 plays essential roles in maintaining mitochondrial structure and function:
Mitochondrial Morphology
Oxidative Phosphorylation
CHCHD9 supports proper oxidative phosphorylation through several mechanisms:
| Complex | Role of CHCHD9 |
|---|---|
| Complex I (NADH dehydrogenase) | Assembly and stability |
| Complex III (Cytochrome bc1) | Electron transfer |
| Complex IV (Cytochrome c oxidase) | Assembly and function |
| Complex V (ATP synthase) | Coupling efficiency |
Electron Transport Chain
The CHCHD domain proteins are characterized by their ability to:
CHCHD9 participates in cellular stress response pathways:
Oxidative Stress Response
Apoptosis Regulation
CHCHD9 interacts with several key mitochondrial proteins:
| Interactor | Function | Reference |
|---|---|---|
| CHCHD2 | Mitochondrial protein complex | [1] |
| CHCHD10 | Protein stability | [1:1] |
| Complex I subunits | ETC assembly | [@ors2017] |
| Complex IV subunits | ETC assembly | [@ors2017] |
| Mitochondrial DNA | Genome maintenance | [2] |
| HAX1 | Anti-apoptotic function | [3] |
CHCHD9 is expressed in various tissues with high expression in:
Within the brain, CHCHD9 shows regional specificity:
| Region | Expression Level | Cell Type |
|---|---|---|
| Cerebral Cortex | High | Pyramidal neurons |
| Hippocampus | High | CA1-CA3 pyramidal cells |
| Cerebellum | Moderate | Purkinje cells |
| Substantia Nigra | Moderate | Dopaminergic neurons |
| Basal Ganglia | Moderate | Medium spiny neurons |
Within cells, CHCHD9 localizes to:
CHCHD9 expression is regulated by:
CHCHD9 has been implicated in Parkinson's disease through several mechanisms:
Mitochondrial Dysfunction
Genetic Association
α-Synuclein Interaction
Evidence suggests CHCHD9 plays a role in Alzheimer's disease pathogenesis:
Mitochondrial Failure
Oxidative Stress
Amyloid-Beta Effects
CHCHD9 relevance to ALS:
CHCHD9 represents a therapeutic target for:
| Strategy | Approach | Status |
|---|---|---|
| Mitochondrial enhancers | Improve ETC function | Preclinical |
| Antioxidant therapy | Reduce oxidative stress | In development |
| Gene therapy | Increase CHCHD9 expression | Experimental |
| Small molecule stabilizers | Stabilize CHCHD9 protein | Discovery |